RxDoctor Payments Data

Bryan Netolicky, MD

Psychiatry · Cedar Rapids, IANPI 1255405338

Payments from drug & device makers

$447in general payments, 2019–2025

Across 25 payments — averaging $17.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Supernus Pharmaceuticals, Inc.$129
  • E.r. Squibb & Sons, L.L.C.$114
  • Adlon Therapeutics L.p.$54
  • Corium, LLC$34
  • Teva Pharmaceuticals USA, Inc.$24
  • Brainsway USA Inc$21
  • plus $70 from 5 others

What the payments were for

  • Food & beverage$447100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$447 in reported general payments places this provider in the 70th percentile of 245 psychiatry providers in Iowa.

See all psychiatry providers in Iowa

Medicare billing

Part B allowed, 2024
$49,722
Medicare patients
150
Services billed
588

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl114$166,470
IngrezzaValbenazine Tosylate11$78,114
Invega SustennaPaliperidone Palmitate12$37,320
RexultiBrexpiprazole28$37,030
TrintellixVortioxetine Hydrobromide53$31,347
LybalviOlanzapine/Samidorphan Malate18$30,737
ZyprexaOlanzapine24$24,509
CaplytaLumateperone Tosylate14$21,253
Olanzapine124$9,288
Asenapine Maleate13$9,059
Clozapine94$7,991
Bupropion XlBupropion Hcl272$6,437
QuviviqDaridorexant Hcl12$6,030
Duloxetine Hcl316$6,028
Buspirone Hcl379$5,440

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$20$166,470114 claims
Neurocrine Biosciences, Inc.Ingrezza$12$78,11411 claims
Johnson & JohnsonInvega Sustenna$14$37,32012 claims
Almatica Pharma LLCSertraline Hcl$13$1,840221 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 245 psychiatry providers in Iowa.

Other psychiatry in Cedar Rapids

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →